3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
20
Vitamin D Deficiency
17
Prostatic Neoplasms
14
Neoplasms
9
Polycystic Ovary Syndrome
8
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Myelodysplastic Syndromes
5
Osteoporosis
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
AZD 6244
9
Lovastatin
5
Deoxycholic Acid
4
trametinib
3
Lasers, Solid-State
3
mirdametinib
2
fludarabine
2
Transcranial Direct Current Stimulation
2
Sirolimus
2
Polidocanol
2
Magnetic Resonance Imaging
2
Lasers
2
Lamotrigine
2
Inhalation
2
Acetylcysteine
2
thymoglobulin
1
talimogene laherparepvec
1
peginterferon alfa-2b
1
gadolinium compound P760
1
fludarabine phosphate
1
diphenylcyclopropenone
1
cabozantinib
1
binimetinib
1
X-Rays
1
Vitamin D
1
Vincristine
1
Vinblastine
1
Temozolomide
1
Surgical Procedures, Operative
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurofibromatosis 1
×
Cholecalciferol
×
Clear all
NCT01968590
2022-05-25
VitDBoneNF1
University of Utah
Phase 2
Terminated
26 enrolled